XML 90 R46.htm IDEA: XBRL DOCUMENT
v3.22.4

Related party transactions | 12 Months Ended
--- | ---
Dec. 31, 2022
Related Party [Abstract] |
Related party transactions | Related party transactions The principal related parties are companies over which Sanofi has control or significant influence, joint ventures, key management personnel, and principal shareholders. Sanofi has not entered into any material transactions with any key management personnel. Financial relations with Sanofi’s principal shareholders fall within the ordinary course of business and were immaterial in the years ended December 31, 2022, 2021 and 2020. Note F.1. lists the principal companies controlled by Sanofi; those companies are fully consolidated, as described in Note B.1. Transactions between those companies, and between the parent company and its subsidiaries, are eliminated when preparing the consolidated financial statements. Transactions with companies over which Sanofi has significant influence, and with joint ventures, are presented in Note D.6. Key management personnel include corporate officers and the members of the Executive Committee (an a verage of 11 members in 2022, in 2021 and in 2020). The table below shows, by type, the compensation paid to key management personnel:
(€ million) | 2022 | 2021 |  | 2020 | (a)
Short-term benefits(b) | 31 |  | 33 |  |  | 36 |  |
Post-employment benefits | 2 |  | 2 |  |  | 3 |  |
Share-based payment | 19 |  | 20 |  |  | 18 |  |
Total recognized in profit or loss | 52 |  | 55 |  |  | 57 |  |
(a) Includes the impact of the April 2021 IFRIC agenda decision on the allocation of benefits to service periods (see Note A.2.1. to the consolidated financial statements for the year ended December 31, 2021). (b) Compensation, employer’s social security contributions, directors’ attendance fees, and any termination benefits (net of reversals of termination benefit obligations). The table below shows the aggregate obligation as of December 31 for each period presented for individuals who hold or have held executive positions within Sanofi during that period.
(€ million) | 2022 | 2021 |  | 2020 | (a)
Aggregate top-up pension obligation in favor of certain corporate officers and of Executive Committee members | 10 |  | 28 |  |  | 32 |  |
Aggregate termination benefits and lump-sum retirement benefits in favor of key management personnel | 5 |  | 7 |  |  | 5 |  |
(a) Includes the impact of the April 2021 IFRIC agenda decision on the allocation of benefits to service periods (see Note A.2.1. to the consolidated financial statements for the year ended December 31, 2021).

X
- Definition The entire disclosure for related parties. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 24 -IssueDate 2021-01-01 -Section Disclosures -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI -URIDate 2021-03-24 + Details
Name: | ifrs-full_DisclosureOfRelatedPartyExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Related Party [Abstract] + References No definition available. + Details
Name: | sny_RelatedPartyAbstract
Namespace Prefix: | sny_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration